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The effect of interferon on the expression of the 
vesicular stomatitis virus glycoprotein G gene was  ex- 
amined in simian COS cells transfected with the 
expression vector pSVGL containing the G gene under 
the control of the SV40 late promoter. When  COS cells 
were treated with interferon 24 h after transfection, 
the synthesis of vesicular stomatitis virus G protein 
was inhibited by about 80% as compared to that in 
untreated controls. By contrast, under the same con- 
ditions, neither the plasmid copy number nor the G 
gene mRNA levels  were detectably affected by inter- 
feron treatment. Likewise, the synthesis of simian vi- 
rus 40 large T-antigen was not inhibited by interferon 
treatment of transfected COS cells even though the 
synthesis of vesicular stomatitis virus G protein was 
markedly inhibited. The residual G protein synthesized 
in transfected, interferon-treated COS cells appeared 
to  be normally glycosylated. 
Interferons are a family of regulatory proteins that pro- 
foundly  affect a number of biologic processes in  animal cells 
including their ability to support the replication of a wide 
range of RNA  and  DNA  animal viruses (1-3). In  many  animal 
virus-host cell systems,  the  principal  step of viral replication 
inhibited by IFN’  is  the  synthesis of virus-specific  macromol- 
ecules. Previous  studies by this  laboratory using highly puri- 
fied,  molecularly  cloned human  IFN-a  and employing vesic- 
ular  stomatitis  virus (VSV) as  the challenge virus have  shown 
that the major and possibly only effect of IFN-a on VSV 
replication  in  human  amnion U  cells is  translation  inhibition 
(4-6). The translation of VSV primary transcripts within 
IFN-a-treated, VSV-infected U cells is selectively inhibited 
under conditions where overall cellular protein  synthesis  is 
unaffected by IFN-a  treatment (5, 6). The  inhibition of VSV 
primary  protein  synthesis by IFN-a does not involve a de- 
tectable  quantitative or qualitative effect of IFN-a  on VSV 
primary mRNA synthesis. Neither the structural nor the 
functional integrity of VSV mRNA is affected by IFN-a 
treatment  as  measured by Northern gel-blot  hybridization or 
by in vitro translation of viral  mRNA  synthesized in vivo (5 ,  
6). 
In  contrast  to  the specific IFN-mediated  inhibition of the 
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translation of VSV transcripts in vivo, the mode of action of 
IFN-a  on SV40 replication  in permissive  cells appears  to be 
mediated a t  a step  other  than  the  inhibition of viral mRNA 
translation. Various lines of evidence indicate that a very 
early  step  in SV40  replication,  possibly the  uncoating of SV40 
virions, is inhibited by IFN-a  treatment of simian cells prior 
to infection with virions (7-12). IFN  treatment of simian cells 
after  infection  with  intact SV40 virions does not reduce the 
synthesis of early or late  RNA  and polypeptides or yield of 
infectious SV40 progeny (8-10) even though the cells are 
IFN-sensitive,  as measured by the  inhibition of reovirus poly- 
peptide  synthesis  in cells  doubly  infected with reovirus and 
SV40 (8, 9). Furthermore,  the  synthesis of SV40 early  RNA, 
T-antigen,  and  DNA  is  not significantly inhibited in simian 
cells pretreated with IFN  and  then  transfected with  free  SV40 
DNA  (7).  In  SV40-transformed mouse cells, neither T- nor t -  
antigen  synthesis is inhibited by IFN (11, 12). These  obser- 
vations collectively indicate that the translation of SV40 
mRNAs, like that of most cellular  mRNAs, is  not adversely 
affected by IFN treatment under conditions that lead to 
reduced VSV and reovirus mRNA  translation. 
A direct  experimental  approach  toward  understanding  the 
structural  basis of the  IFN-induced  inhibition of viral mRNA 
translation  and  the selective discrimination of the  inhibition 
is  to  transfect  animal cells with suitable  recombinant  DNA 
vectors containing individual viral genes and  then  to  study 
the  transient expression of these genes as a function of IFN 
treatment before and after the introduction of controlled 
alterations in their sequences. In view of the differential 
sensitivities of SV40 as compared to VSV and reovirus 
mRNAs  toward  the  IFN-mediated  inhibition of protein  syn- 
thesis  in  simian cells (5 ,  9), the gene coding  for the G protein 
of VSV was expressed in  simian  COS cells under  the  control 
of the SV40 late  promoter,  and  the  effect of human  IFN-a  on 
its expression was examined. In  this  study, we present evi- 
dence that the VSV G gene in an SV40 vector retains its 
sensitivity to IFN at the level of protein synthesis after 
transfection  into  an  IFN-sensitive  simian cell. 
EXPERIMENTAL  PROCEDURES 
Materials-Plasmid vectors pSVGL and pGR125 (14) were gener- 
ously provided by Dr. J. K. Rose, Salk Institute, San Diego, CA. 
DEAE-dextran (average M, 500,000) was obtained from Pharmacia 
P-L Biochemicals; protein A-Sepharose, chloroquine diphosphate, 
and tunicamycin were purchased from Sigma. The sources of all other 
materials have been described (5, 14). 
Cells, Virus, and ZFN-COS-1 cells were  grown in Dulbecco’s 
modified  Eagle’s  medium (DMEM) supplemented with 5% fetal calf 
serum, 100 units/ml penicillin, and 100 pg/ml streptomycin. Stocks 
of the Indiana serotype of  VSV were obtained from confluent mono- 
layers of mouse L929 cells as described (4). Sendai virus-induced 
human leukocyte IFN-a was generously provided by Dr. K. Cantell, 
Central Public Health Laboratory, Helsinki, Finland. The specific 
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activity was  1.9 X lo6 units/mg of protein. 
Measurement of the Antiviral State against VSV in COS Cells- 
The induction of antiviral activity against VSV as a function of IFN 
concentration or duration of IFN treatment was measured as the 
reduction of single cycle virus yield essentially as described earlier 
(4) except that monolayers of COS cells (LUX 21-cm2 dishes) were 
used instead of human amnion  U cells. 
Transfection of COS Cells-Monolayer cultures (LUX 21-cm2 
dishes) of COS cells that were about 75% confluent were transfected 
with pSVGL using the DEAE-dextran technique (15). Medium  was 
removed by aspiration, and 1 ml of serum-free DMEM containing 
600 pg/ml DEAE-dextran and 20 pg/ml plasmid DNA was added. 
After 30 min at 37  "C, the transfection medium was  removed and 3 
ml  of DMEM  containing 5% fetal calf serum and 100 p~ chloroquine 
diphosphate was added (16); the dishes were then incubated for 3 h 
at 37 "C.  After this period, the chloroquine-containing medium  was 
removed, and the monolayers were washed two times with cold 
phosphate-buffered saline. Cells were then briefly trypsinized, col- 
lected by scraping, resuspended in DMEM containing 5% serum, and 
washed twice by centrifugation in the same medium. Cells were 
reseeded at one-half their original density. For the mock transfec- 
tions, the same procedure was also carried out on  COS cells but with 
the omission of plasmid DNA during  transfection. Twenty-four hours 
post-transfection, dishes received either  3 ml of fresh medium (un- 
treated) or medium containing IFN-a at a concentration of 1000 
units/ml if not otherwise stated  (IFN-treated). 
Labeling and Analysis of Proteins Synthesized in Vivo in COS 
Cells-Monolayer cultures of COS cells, either  transfected  or  not and 
then left untreated  or IFN-treated for 24 h as indicated, were washed 
with methionine-free DMEM and  then incubated for 1 h at 37 "C in 
methionine-free DMEM containing 0.5% fetal calf serum. The me- 
dium was then removed, and the monolayers were washed with 
methionine-free DMEM. Cultures were then labeled with methio- 
nine-free DMEM containing [35S]methionine (100 pCi/ml, 1 m1/60- 
mm dish) for 90 min. The labeling medium was removed, and  the 
cultures were washed with cold phosphate-buffered saline and  then 
lysed by the addition of 1 ml of a 10 mM Tris-HC1 (pH 7.4) buffer 
containing 1% Nonidet P-40,0.4% deoxycholate, 66 mM EDTA, and 
50 pg/ml phenylmethylsulfonyl fluoride. Nuclei were removed by 
centrifugation (12,000 X g, 2 rnin), and 5 p1 of anti-VSV antiserum 
( 6 )  were added to  the  supernatant fraction. After incubation for 16 h 
at 0 "C, antigen-antibody complexes were precipitated with protein 
A-Sepharose, washed three times with cold STN buffer (9, 17), and 
subjected to SDS-polyacrylamide gel electrophoresis and autoradiog- 
raphy as previously described (5). Levels of T-antigen were similarly 
measured in extracts  prepared from parallel [35S]methionine-labeled 
IFN-treated and -untreated dishes using hamster  anti-SV40 T-anti- 
gen serum (9). 
[35S]Methionine-labeled VSV polypeptides, used as markers during 
electrophoresis, were prepared by pulse labeling COS cells 4-4.5 h 
post-infection, essentially as described (5). Labeled VSV polypeptides 
were also prepared from tunicamycin-treated, VSV-infected cells. In 
this case, tunicamycin treatment (0.5 pg/ml) was initiated 1 h  post- 
infection and was continued throughout  the subsequent incubation. 
RNA and DNA Dot-blot Hybridizations-Plasmid DNA and G- 
specific mRNA levels in IFN-treated, pSVGL-transfected cells were 
compared to those in untreated,  transfected cells by dot-blot hybrid- 
ization. For this purpose, dishes parallel to those used for quantitation 
of VSV G protein and SV40 T-antigen were analyzed. For measure- 
ment of DNA  copy number, cellular extracts were prepared by the 
procedure of Hirt (18) and,  in order to hydrolyze RNA, made 0.5 N 
in NaOH and  then incubated for 12 h a t  37 "C (19).  Extracts were 
then heated at 100 "C for 5 min to fragment plasmid DNA (20), 
chilled, neutralized with concentrated HCI, and  then denatured with 
formaldehyde directly as in the case of cytoplasmic RNA extracts as 
described below. For comparison of G gene-specific RNA  levels, the 
direct cytoplasmic dot hybridization procedure of White and Bancroft 
(21) was employed. Dot blots were also examined with purified total 
cytoplasmic RNA (22) prepared from IFN-treated and -untreated 
COS cells. For all dot-blot hybridization analyses, serial 2-fold dilu- 
tions of equal quantities of crude extracts  or purified total RNA  were 
made in 20 X SSC and transferred directly to nitrocellulose using a 
Bethesda Research Laboratories Hybri-Dot manifold (28). 
Filters were probed with plasmid pGR125 containing cDNA to  the 
VSV G gene (13) labeled with [a-32P]dTTP by nick translation (23) 
to a specific activity of 8 X lo7 cpm/pg DNA. Hybridization and 
subsequent washing of filters were done under stringent conditions, 
described in detail earlier (5, 6). Under these conditions, DNA and 
RNA blots of extracts prepared from mock-transfected cells or  RNA 
blots of extracts prepared from transfected cells but which had been 
alkali-treated (0.5 N NaOH, 12 h, 37 "C) and then neutralized prior 
to blotting did not show any detectable hybridization with the labeled 
G gene probe. 
RESULTS 
Induction of the  Antiviral  State in COS Cells-The effect of 
different  concentration doses of human leukocyte IFN  (IFN- 
a )  on  the replication of VSV was examined in simian COS 
cells. As shown in Fig. lA, a progressive inhibition of VSV 
replication  in  COS cells  occurred as a function of treatment 
for 24 h  with increasing  concentrations of IFN-a. At an  IFN 
dose of 300 units/mi,  the yield of infectious VSV progeny was 
reduced by more than 99% relative to that of untreated 
controls.  The  kinetics of induction of the  antiviral  state in 
COS cells  was also  examined (Fig. 1B). The observed kinetic 
curve  exhibited a short  lag period (1-2 h) followed by a rapid 
but biphasic  decline during which the major extent of viral 
inhibition occurred. These observations regarding the IFN 
dose  dependence and  the biphasic kinetics of induction of the 
antiviral  state,  as well as  studies  on  the  IFN-mediated  inhi- 
bition of VSV polypeptide synthesis (data not shown), are 
similar  to  the  results previously obtained during a detailed 
analysis of the  inhibition of VSV replication in  human  amnion 
U cells  by IFN-u (4-6). 
Effect of IFN-u on Protein  Synthesis  in pSVGL-transfected 
COS Cells-In order to study the effect of IFN-u on the 
expression of a single viral gene in the absence of virion 
infection, we chose the expression  vector pJC119  (24)  and  the 
VSV Indiana G gene (13). The expression vector construct 
pSVGL contains the complete coding sequence for VSV G 
protein  under  the  control of the SV40 late  promoter in  pJC119 
(14). The vector can be propagated in simian COS-1 cells 
which support its replication by supplying SV40 large T-  
antigen  (25). The G protein encoded by pSVGL and expressed 
in COS cells is of the correct size, is glycosylated, and is 
functionally  normal (14). 
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FIG. 1. Induction of the antiviral state against VSV in sim- 
ian COS cells treated with IFN-a. A, concentration dose depend- 
ence of the IFN-a-induced antiviral activity against VSV in COS 
cells. Monolayers of COS cells were treated with varying concentra- 
tions of IFN-a for 24 h and  then infected with VSV at a multiplicity 
of 10 plaque-forming units (pfu)/cell in the presence of actinomycin 
D. After 12 h of incubation, viral yields were determined. B, kinetics 
of induction of the antiviral state against VSV in COS cells treated 
with IFN-a. COS cell monolayers were treated with a saturating 
concentration dose  (1000 units/ml) for various lengths of time and 
then infected with VSV in the presence of actinomycin D. The virus 
yields after 12 h were then determined. 
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As shown  in Fig. 2 (lanes 5 and 6), G protein encoded by 
pSVGL was  readily detected in untreated COS-1 cells a t  48 h 
after  transfection by pulse labeling with [:"S]methionine and 
immunoprecipitation. However, if a t  24 h after  transfection 
the COS-1 cells were treated  with a saturating  concentration 
dose of IFN for 24 h and  then pulse-labeled with [:"S]methi- 
onine,  the  amount of G protein  synthesized was significantly 
reduced as  compared  to  untreated cells (Fig. 2, lanes 5-8). In 
contrast  to  the  inhibitory effect of IFN-n  on VSV G protein 
synthesis in transfected COS-1 cells (Fig. 2, lanes 5-8), IFN- 
(Y treatment  with a saturating  concentration dose (1000 units 
of IFN/ml) did not affect SV40  T-antigen  synthesis  in  the 
transfected COS-1 cells  (Fig. 2, lanes 9-12). 
The  extent of IFN-induced  inhibition of G protein  synthesis 
in pSVG1,-transfected cells was dependent upon the IFN 
concentration used to  treat  the COS-1 cells  (Fig. 3). The dose 
dependence for inhibition of G protein  synthesis in  pSVGL- 
transfected COS-I cells  (Fig. 3) was similar  to  that observed 
for inhibition of VSV replication in virion-infected COS-1 
cells (Fig. 1). Likewise, the kinetics of the inhibition of G 
protein  synthesis in IFN-treated  transfected COS cells  were 
similar  to  the  kinetics observed  in the  case of VSV replication 
in virion-infected COS cells (data  not  shown).  The  extent of 
inhibition of IFN  treatment of G protein  synthesis  in  trans- 
fected cells was independent of the extract concentration 
analyzed by immunoprecipitation  and  densitometric  scanning 
(Fig. 4),  further  establishing  the  quantitative  nature of the 
assay. Treatment with 1000 units/ml IFN routinely caused 
about a 5-fold reduction in G protein synthesis in pulse- 
labeled IFN-treated as compared to untreated transfected 
COS-1 cells, as shown  for example by the  results  in Fig.  4. 
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FIG. 2. Effect of IFN-a treatment on the  synthesis of VSV 
G protein and SV40 T-antigen in transfected COS cells. COS 
cells were transfected with pSVGL (lanes 5-12) or mock-transfected 
(lanes 3 and 4 ) .  After 24 h,  cells were either left untreated (lanes 3- 
6, 9, and 10) or  treated with 1000 units/ml  IFN-a (lanes 7, 8, 11, and 
12). Following incubation for 24 h, cells  were  labeled  with [%I 
methionine.  Extracts were prepared,  immunoprecipitated with either 
anti-VSV  antiserum (lanes 3-8) or SV40 anti-T  antiserum (lanes 9- 
12). and analyzed by SDS-PAGE  as described under  "Experimental 
Procedures." IAWS 1 and 2 contained nonimmunoprecipitated ex- 
tracts  made from [RsSS]methionine-laheled, VSV virion-infected COS 
cells either left untreated (lane 1 )  or treated with 0.5 pg/ml tunica- 
mycin ( 7 " )  following infection. The identities of the  various VSV- 
encoded  polypeptides are indicated on  the left  margin. 
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FIG. 3. Concentration dose dependence of  the inhibition of 
G protein synthesis by IFN-a in transfected COS cells. Mono- 
layers of pSVGL-transfected COS cells were either left untreated or 
treated 24 h post-transfection with the indicated concentration doses 
of IFN-a. After 24 h,  cells were pulse-laheled with [:"S]methionine. 
Extracts were then analyzed (as in Fig. 2) by SDS-PAGE  and fluo- 
rography after immunoprecipitation with anti-VSV antiserum as 
described under  "Experimental Procedures." G protein  synthesis  in 
transfected COS cells  was quantitated by densitometric  scanning of 
the fluorograph (inset) using an  LKB Ultroscan XL Laser densitom- 
eter.  The  data were then  plotted  as a  function of increasing  concen- 
tration of IFN-a. 
G protein synthesized in pSVGL-transfected COS-1 cells 
was indistinguishable from authentic G protein synthesized 
in virion-infected COS-1 cells as measured by mobility on 
SDS-PAGE (Fig. 2, lanes 1, 5, and 6). However, the mobility 
of underglycosylated G protein (Go) produced in virion-in- 
fected COS-1 cells as  the result of treatment  with  the glyco- 
sylation inhibitor tunicamycin (26, 27) was readily distin- 
guishable  from  normally glycosylated G protein (Fig. 2, lanes 
1 and 2). Although IFN-n treatment caused about an 80% 
reduction in the amount of G protein synthesized in the 
experiment shown in Fig. 2, the mobility of the residual G 
protein synthesized  in IFN-treated cells was typical of nor- 
mally glycosylated G rather  than underglycosylated Go (Fig. 
2, lanes 1, 2, and 5-8). 
Effect of IFN-n  on Nucleic Acid Synth.esi.s in pSVGL-trans- 
fected COS Cells-The IFN-induced  inhibition in the  synthe- 
sis of G protein observed in pSVGL-transfected COS cells 
(Fig. 2) could potentially be caused by a block either at   the 
level of plasmid  DNA  replication or G  mRNA transcription 
or,  as  demonstrated  in  the case of VSV-infected human  am- 
nion cells (4-6), at  the level of viral mRNA translation.  In 
order  to  distinguish between these possibilities, we measured 
by dot-blot hybridization the levels of plasmid DNA and G 
protein-encoding  mRNA in untreated  as compared to  IFN-n- 
treated COS cells transfected with pSVGL. Quantitation of 
G-specific DNA and RNA  in transfected  cultures (Fig. 5) was 
carried out with cultures in parallel to those in which G 
protein  synthesis was measured (Fig. 2). As shown  in Fig. 5, 
the relative levels of G-specific DNA and RNA in untreated 
and  IFN-treated  transfected cells were comparable. Further- 
more, Northern blot analysis of whole cytoplasmic  RNA  also 
Interferon  Inhibition of VSV 16767 
TOTAL CY TOPL . pSVGL- 400 350 300 200 100 0 
,,SVGL+ 0 50 100 200 300 400 5 
I F N  u-uuu- Y 
- - +  - +  - +  - +  - +  v) 
Reduction - n.d. 
( f o l d )  " _  " 
3.7 5.7 4.9 
L 
5.6 5 
" 
- L  
"G 
- NS "N 
"M 
FIG. 4. Quantitation of  the IFN-induced  inhibition of G pro- 
tein  synthesis in pSVGL-transfected COS cells. Monolayers of 
COS cells were either  mock-transfected or transfected with  pSVGL. 
After 24 h, transfected cells  were either  left  untreated or treated with 
a saturating  concentration dose  (1000 units/ml) of IFN-a. Following 
incubation for 24 h, cells were pulse-labeled with ["S]methionine, 
and  extracts were prepared as described under  "Experimental  Pro- 
cedures." Varying amounts  (0,50,100,200,300,  and 400 pl) of extract 
prepared from either  IFN-treated or -untreated  pSVGL-transfected 
COS cells were then mixed with varying  amounts of extract  prepared 
from mock-transfected COS cells (total volume of mixture = 400 pl) 
and  reacted with  a constant  amount (2.5 pl) of anti-VSV  antiserum. 
Immunoprecipitates were then  analyzed by SDS-PAGE  and fluorog- 
raphy. G protein  synthesis  in  the respective samples was quantitated 
by densitometric  scanning. The fold inhibition of G protein  synthesis 
in IFN-treated cells as compared  to  untreated cells using differing 
amounts of cell extract is indicated. n.d., not  determined. 
did not reveal any  qualitative or quantitative difference be- 
tween  G  gene transcripts formed  in IFN-treated  as  compared 
to  untreated  pSVGL-transfected  COS cells (data  not  shown). 
DISCUSSION 
The  observations  reported in this  paper  strongly  indicate 
that  the  IFN-induced  inhibition of the expression of the VSV 
G  gene under the control of the SV40 late promoter in 
pSVGL-transfected COS cells is brought about at  a step 
subsequent  to  plasmid  DNA replication and  transcription of 
the G  gene  sequence. The  inhibition of G protein  expression 
in transfected cells is possibly exerted at   the  level of transla- 
tion. 
The extent of the inhibition of G protein synthesis in 
transfected cells treated  with a saturating  concentration of 
IFN-(U was typically  between  &fold, as was obtained in most 
experiments (e.g as shown  in Figs. 2 and  4),  and  about 7-fold, 
as was obtained in some experiments (e.g as shown in Fig. 
3). The inhibition of G protein synthesis in pSVGL-trans- 
fected COS cells was not  as  great  as  that observed for the 
inhibition of G protein synthesis in wild-type VSV virion- 
infected cells. In wild-type virion-infected cells, the  inhibition 
of viral  polypeptide synthesis by  a saturating dose of IFN-(U 
is nearly complete (5,6). There  are  two possible explanations 
for this apparent difference. First, primary plus secondary 
expression is affected  in  wild-type  VSV-infected cells, whereas 
conceptually only primary expression is affected in trans- 
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FIG. 5. Dot-blot analysis  of VSV G gene-specific DNA and 
mRNA synthesized in IFN-a-treated COS cells transfected 
with pSVGL. COS cell monolayer cultures parallel to  those analyzed 
for protein  synthesis (Fig. 2) were either  mock-transfected (lanes 1, 
4, and 7) or transfected with  pSVGL (lanes 2, 3, 5, 6, 8, and 9). After 
24 h, transfected cells were either left untreated (-) or IFN-treated 
(+) with  a  dose of 1000 units/ml  IFN-a for 24 h. Monolayers were 
then processed, as described under  "Experimental Procedures," either 
for the  analysis of total G-specific DNA (left panel) or RNA  (center 
panel) present  in  crude cell-free extracts or for the  analysis of purified 
cytoplasmic G-specific RNA  isolated  from crude  extracts (right 
p a d ) .  Reciprocal 2-fold dilutions  (top to bottom in each row) of each 
sample were transferred to nitrocellulose filters  and  then probed  with 
[a-"'PIdTTP-labeled cDNA to  the VSV G gene  mRNA. 
fected  COS cells. Indeed, in previous studies from our labo- 
ratory (4-6), wherein primary  translation was examined di- 
rectly  by  use of the VSV mutant ts  G41 which is temperature- 
sensitive  in  RNA replication, the IFN-induced inhibition  in 
the  translation of VSV primary  transcripts was determined 
to be about 10-fold as compared to  untreated controls.  Second, 
the hybrid  mRNA encoding  the G  protein  in transfected cells 
possesses  significant 5'-untranslated SV40 sequences  preced- 
ing  the  5"untranslated VSV G mRNA nucleotides and  has 
only  7 of the 29 5'-untranslated VSV G mRNA  nucleotides. 
Nevertheless,  in view of the fact that in this simplified model 
system the effect of IFN-n qualitatively approximated  that 
observed in the case of infectious VSV virions, mutational 
analysis of the VSV G gene may permit  the identification of 
regions in  the VSV G  mRNA, if indeed discrete regions  exist, 
that are responsible for its reduced translation after IFN 
treatment. 
It  has been previously reported that  IFN  inhibits  the  on- 
cogenic transformation  and  stable ( i e .  long-term) expression 
of genes of both viral and cellular  origin after  their transfec- 
tion  into  rodent cells by the Capo., technique (31, 32). This 
inhibition seemed to be  exerted at   the level of stabilization 
and/or integration of exogenous DNA sequences into the 
cellular genome. In  contrast,  IFN was found  not to  prevent 
transient gene  expression when the exogenous plasmid DNA 
was present in unintegrated form (32).  Our results concerning 
the effect of IFN-n  on  the  transient expression of the VSV G 
gene are  consistent with these  earlier  studies by Chany  and 
co-workers (32).  Under  conditions where the  synthesis of G 
protein was markedly reduced by IFN  treatment, we found 
that  the levels of plasmid DNA and G-encoding  mRNA were 
essentially unaltered,  thereby suggesting that  the  inhibition 
was brought about a t  a step subsequent to plasmid DNA 
replication and G  mRNA transcription.  The  inhibition of G 
protein expression in  transfected cells was thus possibly ex- 
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erted at  the level of translation. 
Finally, the observation that the reduced amount of G 
protein  synthesized in IFN-treated,  transfected  simian COS 
cells was apparently normally glycosylated is  consistent with 
prior  studies from our  laboratory  on  the effect of IFN-a  on 
VSV replication in human U cells (4-6). By contrast, Ma- 
heshwari et ul. (29, 30) have reported that IFN treatment 
causes  the underglycosylation of VSV G protein  to  an  extent 
comparable  with  that observed in  tunicamycin-treated VSV- 
infected cells. 
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